70
Views
1
CrossRef citations to date
0
Altmetric
Original

Tenascin‐C levels in pseudosynovial fluid of loose hip prostheses

, , , , , & show all
Pages 464-468 | Received 19 Dec 2004, Accepted 18 Apr 2005, Published online: 12 Jul 2009

References

  • Harris W. H. Wear and periprosthetic osteolysis: the problem. Clin Orthop 2001; 393: 66–70
  • Mazzucco D., Scott R., Spector M. Composition of joint fluid in patients undergoing total knee replacement and revision arthroplasty: correlation with flow properties. Biomaterials 2004; 25: 4433–45
  • Konttinen Y. T., Li T. F., Xu J. W., Takagi M., Pirila L., Silvennoinen T., et al. Expression of laminins and their integrin receptors in different conditions of synovial membrane and synovial membrane‐like interface tissue. Ann Rheum Dis 1999; 58: 683–90
  • Li T. F., Xu J. W., Santavirta S., Takagi M., Virtanen I., Pirila L., et al. Expression of vitronectin and its integrin receptors in the synovial membrane‐like interface tissue from aseptic loosening of total hip replacement. J Rheumatol 2000; 27: 727–34
  • Konttinen Y. T., Li T. F., Michelsson O., Xu J. W., Sorsa T., Santavirta S., et al. Expression of tenascin‐C in aseptic loosening of total hip replacement. Ann Rheum Dis 1998; 57: 619–23
  • Spring J., Beck K., Chiquet‐Ehrismann R. Two contrary functions of tenascin: dissection of the active sites by recombinant tenascin fragments. Cell 1989; 59: 325–34
  • Jones P. L., Jones F. S. Tenascin‐C in development and disease: gene regulation and cell function. Matrix Biology 2000; 19: 581–96
  • Tsunoda T., Inada H., Kalembeyi I., Imanaka‐Yoshida K., Sakakibara M., Okada R., et al. Involvement of large tenascin‐C splice variants in breast cancer progression. Am J Pathol 2003; 162: 1857–67
  • Chiquet‐Ehrismann R., Mackie E. J., Pearson C. A., Sakakura T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 1986; 47: 131–9
  • Mackie E. J., Murphy L. I. The role of tenascin‐C and related glycoproteins in early chondrogenesis. Microscop Res Technol 1998; 43: 102–10
  • Hasegawa M., Hirata H., Sudo A., Kato K., Kawase D., Kinoshita N., et al. Tenascin‐C concentration in synovial fluid correlates with radiographic progression of knee osteoarthritis. J Rheumatol 2004; 31: 2021–6
  • Harris W. H., McCarthy J. C Jr., O'Neill D. A. Femoral component loosening using contemporary techniques of femoral cement fixation. J Bone Joint Surg Am 1982; 64: 1063–7
  • Engh C. A., Bobyn J. D., Glassman A. H. Porous‐coated hip replacement. The factors governing bone ingrowth, stress shielding, and clinical results. J Bone Joint Surg Br 1987; 69: 45–55
  • Hodgkinson J. P., Shelley P., Wroblewski B. M. The correlation between the roentgenographic appearance and operative findings at the bone–cement junction of the socket in Charnley low friction arthroplasties. Clin Orthop 1988; 228: 105–9
  • Mulroy R. D Jr., Harris W. H. Failure of acetabular autogenous grafts in total hip arthroplasty. Increasing incidence: a follow‐up note. J Bone Joint Surg Am 1990; 72: 1536–40
  • Imanaka‐Yoshida K., Hiroe M., Yasutomi Y., Toyozaki T., Tsuchiya T., Noda N., et al. Tenascin‐C is a useful marker for disease activity in myocarditis. J Pathol 2002; 197: 388–94
  • Robertsson O., Wingstrand H., Kesteris U., Jonsson K., Onnerfalt R. Intracapsular pressure and loosening of hip prostheses. Preoperative measurements in 18 hips. Acta Orthop Scand 1997; 68: 231–4
  • Schmalzried T. P., Jasty M., Harris W. H. Periprosthetic bone loss in total hip arthroplasty. Polyethylene wear debris and the concept of the effective joint space. J Bone Joint Surg Am 1992; 74: 849–63
  • Nivbrant B., Karlsson K., Karrholm J. Cytokine levels in synovial fluid from hips with well‐functioning or loose prostheses. J Bone Joint Surg Br 1999; 81: 163–6
  • Clarke S. A., Brooks R. A., Hobby J. L., Wimhurst J. A., Myer B. J., Rushton N. Correlation of synovial fluid cytokine levels with histological and clinical parameters of primary and revision total hip and total knee replacements. Acta Orthop Scand 2001; 72: 491–8
  • Rettig W. J., Erickson H. P., Albino A. P., Garin‐Chesa P. Induction of human tenascin (neuronectin) by growth factors and cytokines: cell type‐specific signals and signalling pathways. J Cell Sci 1994; 107: 487–97
  • McCachren S. S., Lightner V. A. Expression of human tenascin in synovitis and its regulation by interleukin‐1. Arthritis Rheum 1992; 35: 1185–96
  • Mackie E. J., Scott‐Burden T., Hahn A. W., Kern F., Bernhardt J., Regenass S., et al. Expression of tenascin by vascular smooth muscle cells. Alterations in hypertensive rats and stimulation by angiotensin II. Am J Pathol 1992; 141: 377–88
  • Tucker R. P., Hammarback J. A., Jenrath D. A., Mackie E. J., Xu Y. Tenascin expression in the mouse: in situ localization and induction in vitro by bFGF. J Cell Sci 1993; 104: 69–76
  • Pearson C. A., Pearson D., Shibahara S., Hofsteenge J., Chiquet‐Ehrismann R. Tenascin: cDNA cloning and induction by TGF‐beta. EMBO J 1988; 7: 2977–82
  • Waris V., Xu J. W., Nordsletten L., Sorsa T., Santavirta S., Konttinen Y. T. Basic fibroblast growth factor (bFGF) in the synovial‐like membrane around loose total hip prostheses. Scand J Rheumatol 1996; 25: 257–62
  • Goodman S. B., Huie P., Song Y., Lee K., Doshi A., Rushdieh B., et al. Loosening and osteolysis of cemented joint arthroplasties. A biologic spectrum. Clin Orthop 1997; 337: 149–63
  • Konttinen Y. T., Waris V., Xu J. W., Jiranek W. A., Sorsa T., Virtanen I., et al. Transforming growth factor‐beta 1 and 2 in the synovial‐like interface membrane between implant and bone in loosening of total hip arthroplasty. J Rheumatol 1997; 24: 694–701
  • Xu J. W., Konttinen Y. T., Li T. F., Waris V., Lassus J., Matucci‐Cerinic M., et al. Production of platelet‐derived growth factor in aseptic loosening of total hip replacement. Rheumatol Int 1998; 17: 215–21
  • Jarvinen T. A., Jozsa L., Kannus P., Jarvinen T. L., Kvist M., Hurme T., et al. Mechanical loading regulates tenascin‐C expression in the osteotendinous junction. J Cell Sci 1999; 112: 3157–66
  • Chiquet M., Sarasa‐Renedo A., Tunc‐Civelek V. Induction of tenascin‐C by cyclic tensile strain versus growth factors: distinct contributions by Rho/ROCK and MAPK signaling pathways. Biochim Biophys Acta 2004; 1693: 193–204
  • Tremble P., Chiquet‐Ehrismann R., Werb Z. The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. Mol Biol Cell 1994; 5: 439–53
  • Imai S., Konttinen Y. T., Jumppanen M., Lindy O., Ceponis A., Kemppinen P., et al. High levels of expression of collagenase‐3 (MMP‐13) in pathological conditions associated with a foreign‐body reaction. J Bone Joint Surg Br 1998; 80: 701–10
  • Takei I., Takagi M., Santavirta S., Ida H., Hamasaki M., Ishii M., et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints. J Biomed Mater Res 1999; 45: 175–83
  • Syggelos S. A., Eleftheriou S. C., Giannopoulou E., Panagiotopoulos E., Aletras A. J. Gelatinolytic and collagenolytic activity in periprosthetic tissues from loose hip endoprostheses. J Rheumatol 2001; 28: 1319–29
  • Kovacik M. W., Gradisar I. A Jr., Haprian J. J., Alexander T. S. Osteolytic indicators found in total knee arthroplasty synovial fluid aspirates. Clin Orthop 2000; 379: 186–94

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.